Skip to main content
. 2020 Jan 30;106(1):46–55. doi: 10.3324/haematol.2019.237230

Figure 3.

Figure 3.

Overall outcomes for all eligible patients. (A) Event-free survival (EFS) curves, 3-year and 5-year EFS: 63.6±3.0%, and EFS 51.0%±3.5%, respectively. (B) Overall survival (OS), 3-year and 5-year OS 72.3±2.8%, and OS 62.9±3.3%, respectively.